Sophiris Bio Inc. (SPHS)
Sophiris Bio has 34.47 million shares outstanding. The number of shares has increased by 6.51% in one year.
|Shares Change (YoY)||+6.51%|
|Shares Change (QoQ)||+6.14%|
|Owned by Insiders (%)||n/a|
|Owned by Institutions (%)||0.03%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 1.79, with a Debt / Equity ratio of n/a.
|Debt / Equity||n/a|
|Debt / EBITDA||7.57|
|Debt / FCF||n/a|
Return on equity (ROE) is -3.90%, which is considered low. The company has a high ROIC of 16.00%.
|Return on Equity (ROE)||-3.90%|
|Return on Assets (ROA)||0.40%|
|Return on Capital (ROIC)||16.00%|
|Revenue Per Employee||n/a|
|Profits Per Employee||$6,167|
|Effective Tax Rate||n/a|
Stock Price Statistics
. The beta is 1.93, so Sophiris Bio's price volatility has been higher than the market average.
|52-Week Price Change||n/a|
|50-Day Moving Average||n/a|
|200-Day Moving Average||0.01|
|Average Volume (30 Days)||n/a|
Short Selling Information
|Short % of Shares Out||4.11%|
|Short % of Float||4.34%|
|Short Ratio (days to cover)||8.61|
|Earnings Per Share (EPS)||$0.00|
The company has $6.30 million in cash and $5.84 million in debt, giving a net cash position of $465,000 or $0.01 per share.
|Cash & Cash Equivalents||6.30M|
|Net Cash Per Share||$0.01|
|Book Value Per Share||-0.08|
|Operating Cash Flow||-10.54M|
|Free Cash Flow||-10.54M|
|FCF Per Share||n/a|
Dividends & Yields
Sophiris Bio does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The last stock split was on August 15, 2013. It was a reverse split with a ratio of 1:52.
|Last Split Date||Aug 15, 2013|